A petition by patent litigation outfit Cellect that is seeking to persuade the U.S. Supreme Court to involve itself in a double patenting dispute has garnered notable support. This backing includes endorsements from prominent drug companies and various small tech firms, such as Sonos. The case represents a significant juncture in patent law, distinguishing between inventions and their protections in a landscape increasingly characterized by complex intellectual property rights.
For further details on this development, follow this link.